BeiGene And NewBridge Pharmaceuticals Announce Approval In Saudi Arabia Of BRUKINSA (Zanubrutinib)…
BRUKINSA is now approved for the treatment of MCL in 11 countries and regions, including the United States, China, Canada, Australia, Brazil, the…